Head And Neck Cancer - Pipeline Review, H2 2017

  • ID: 4419039
  • Report
  • 1466 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • BioDiem Ltd
  • Eli Lilly and Co
  • Incyte Corp
  • Moderna Therapeutics Inc
  • PNP Therapeutics Inc
  • MORE
Head And Neck Cancer - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2017, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 18, 96, 115, 5, 85, 18 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 12, 7, 16 and 3 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • BioDiem Ltd
  • Eli Lilly and Co
  • Incyte Corp
  • Moderna Therapeutics Inc
  • PNP Therapeutics Inc
  • MORE
Introduction

Head And Neck Cancer - Overview

Head And Neck Cancer - Therapeutics Development

Head And Neck Cancer - Therapeutics Assessment

Head And Neck Cancer - Companies Involved in Therapeutics Development

Head And Neck Cancer - Drug Profiles

Head And Neck Cancer - Dormant Projects

Head And Neck Cancer - Discontinued Products

Head And Neck Cancer - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Head And Neck Cancer, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Products under Development by Companies, H2

Products under Development by Universities/Institutes, H2

Number of Products by Stage and Target, H2

Number of Products by Stage and Mechanism of Action, H2

Number of Products by Stage and Route of Administration, H2

Number of Products by Stage and Molecule Type, H2

Head And Neck Cancer - Pipeline by 3SBio Inc, H2

Head And Neck Cancer - Pipeline by 4SC AG, H2

Head And Neck Cancer - Pipeline by AbbVie Inc, H2

Head And Neck Cancer - Pipeline by Abion Inc, H2

Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2

Head And Neck Cancer - Pipeline by Aduro BioTech Inc, H2

Head And Neck Cancer - Pipeline by Advaxis Inc, H2

Head And Neck Cancer - Pipeline by Advenchen Laboratories LLC, H2

Head And Neck Cancer - Pipeline by Affimed GmbH, H2

Head And Neck Cancer - Pipeline by Altor BioScience Corp, H2

Head And Neck Cancer - Pipeline by Ambrx Inc, H2

Head And Neck Cancer - Pipeline by amcure GmbH, H2

Head And Neck Cancer - Pipeline by Amgen Inc, H2

Head And Neck Cancer - Pipeline by arGEN-X BV, H2

Head And Neck Cancer - Pipeline by ArQule Inc, H2

Head And Neck Cancer - Pipeline by Array BioPharma Inc, H2

Head And Neck Cancer - Pipeline by Ascentage Pharma Group Corp Ltd, H2

Head And Neck Cancer - Pipeline by Aspyrian Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Astellas Pharma Inc, H2

Head And Neck Cancer - Pipeline by Astex Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2

Head And Neck Cancer - Pipeline by Atara Biotherapeutics Inc, H2

Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Bayer AG, H2

Head And Neck Cancer - Pipeline by BeiGene Ltd, H2

Head And Neck Cancer - Pipeline by Benitec Biopharma Ltd, H2

Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals LLC, H2

Head And Neck Cancer - Pipeline by BioDiem Ltd, H2

Head And Neck Cancer - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2

Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H2

Head And Neck Cancer - Pipeline by Bionovis SA, H2

Head And Neck Cancer - Pipeline by BioNTech AG, H2

Head And Neck Cancer - Pipeline by Biotest AG, H2

Head And Neck Cancer - Pipeline by Biothera Pharmaceutical Inc, H2

Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2

Head And Neck Cancer - Pipeline by Boston Biomedical Inc, H2

Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Co, H2

Head And Neck Cancer - Pipeline by CBT Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by CEL-SCI Corp, H2

Head And Neck Cancer - Pipeline by Celgene Corp, H2

Head And Neck Cancer - Pipeline by Cell Medica Ltd, H2

Head And Neck Cancer - Pipeline by Celldex Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Cellectar Biosciences Inc, H2

Head And Neck Cancer - Pipeline by Celprogen Inc, H2

Head And Neck Cancer - Pipeline by Centrose LLC, H2

Head And Neck Cancer - Pipeline by Checkpoint Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Corvus Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Cristal Therapeutics BV, H2

Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc, H2

Head And Neck Cancer - Pipeline by Curevac AG, H2

Head And Neck Cancer - Pipeline by Cyclacel Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by CytImmune Sciences Inc, H2

Head And Neck Cancer - Pipeline by CytomX Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Daiichi Sankyo Co Ltd, H2

Head And Neck Cancer - Pipeline by Denceptor Therapeutics Ltd, H2

Head And Neck Cancer - Pipeline by DNJ Pharma Inc, H2

Head And Neck Cancer - Pipeline by Dynavax Technologies Corp, H2

Head And Neck Cancer - Pipeline by Eisai Co Ltd, H2

Head And Neck Cancer - Pipeline by Eleven Biotherapeutics Inc, H2

Head And Neck Cancer - Pipeline by Eli Lilly and Co, H2

Head And Neck Cancer - Pipeline by Enzene Biosciences Ltd, H2

Head And Neck Cancer - Pipeline by Etubics Corp, H2

Head And Neck Cancer - Pipeline by Eureka Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2

Head And Neck Cancer - Pipeline by Forty Seven Inc, H2

Head And Neck Cancer - Pipeline by Fujifilm Corp, H2

Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co Ltd, H2

Head And Neck Cancer - Pipeline by Galectin Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Genelux Corp, H2

Head And Neck Cancer - Pipeline by Genentech Inc, H2

Head And Neck Cancer - Pipeline by GeneSegues Inc, H2

Head And Neck Cancer - Pipeline by Genexine Inc, H2

Head And Neck Cancer - Pipeline by Genmab A/S, H2

Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2

Head And Neck Cancer - Pipeline by Glenmark Pharmaceuticals Ltd, H2

Head And Neck Cancer - Pipeline by Gliknik Inc, H2

Head And Neck Cancer - Pipeline by Glycotope GmbH, H2

Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2

Head And Neck Cancer - Pipeline by Hookipa Biotech AG, H2

Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2

Head And Neck Cancer - Pipeline by Hutchison MediPharma Ltd, H2

Head And Neck Cancer - Pipeline by Ignyta Inc, H2

Head And Neck Cancer - Pipeline by Immatics Biotechnologies GmbH, H2

Head And Neck Cancer - Pipeline by Immunocore Ltd, H2

Head And Neck Cancer - Pipeline by Immunomedics Inc, H2

Head And Neck Cancer - Pipeline by Immunovaccine Inc, H2

Head And Neck Cancer - Pipeline by Immunovative Therapies Ltd, H2

Head And Neck Cancer - Pipeline by Incyte Corp, H2

Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Innate Pharma SA, H2

Head And Neck Cancer - Pipeline by Innovation Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by InteRNA Technologies BV, H2

Head And Neck Cancer - Pipeline by Iovance Biotherapeutics Inc, H2

Head And Neck Cancer - Pipeline by IRX Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by ISA Pharmaceuticals BV, H2

Head And Neck Cancer - Pipeline by ISU ABXIS Co Ltd, H2

Head And Neck Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2

Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2

Head And Neck Cancer - Pipeline by Johnson & Johnson, H2

Head And Neck Cancer - Pipeline by Jounce Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Juno Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Kite Pharma Inc, H2

Head And Neck Cancer - Pipeline by Kura Oncology Inc, H2

Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2

Head And Neck Cancer - Pipeline by LATITUDE Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Loxo Oncology Inc, H2

Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2

Head And Neck Cancer - Pipeline by Mabion SA, H2

Head And Neck Cancer - Pipeline by MacroGenics Inc, H2

Head And Neck Cancer - Pipeline by Madrigal Pharmaceuticals Inc., H2

Head And Neck Cancer - Pipeline by Marsala Biotech Inc, H2

Head And Neck Cancer - Pipeline by Mateon Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by MaxiVAX SA, H2

Head And Neck Cancer - Pipeline by Meabco A/S, H2

Head And Neck Cancer - Pipeline by MedImmune LLC, H2

Head And Neck Cancer - Pipeline by Merck & Co Inc, H2

Head And Neck Cancer - Pipeline by Merck KGaA, H2

Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Moderna Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Molecular Templates Inc, H2

Head And Neck Cancer - Pipeline by Moleculin Biotech Inc, H2

Head And Neck Cancer - Pipeline by NanoCarrier Co Ltd, H2

Head And Neck Cancer - Pipeline by NantKwest Inc, H2

Head And Neck Cancer - Pipeline by Natco Pharma Ltd, H2

Head And Neck Cancer - Pipeline by NeoImmuneTech Inc, H2

Head And Neck Cancer - Pipeline by Neonc Technologies Inc, H2

Head And Neck Cancer - Pipeline by Neumedicines Inc, H2

Head And Neck Cancer - Pipeline by Northwest Biotherapeutics Inc, H2

Head And Neck Cancer - Pipeline by Novartis AG, H2

Head And Neck Cancer - Pipeline by Noxopharm Ltd, H2

Head And Neck Cancer - Pipeline by Oncobiologics Inc, H2

Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc, H2

Head And Neck Cancer - Pipeline by Onconova Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by OncoSec Medical Inc, H2

Head And Neck Cancer - Pipeline by Oncovir Inc, H2

Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2

Head And Neck Cancer - Pipeline by Oryx GmbH & Co KG, H2

Head And Neck Cancer - Pipeline by Otsuka Holdings Co Ltd, H2

Head And Neck Cancer - Pipeline by PDS Biotechnology Corp, H2

Head And Neck Cancer - Pipeline by Peregrine Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Pfizer Inc, H2

Head And Neck Cancer - Pipeline by Pharma Mar SA, H2

Head And Neck Cancer - Pipeline by Plexxikon Inc, H2

Head And Neck Cancer - Pipeline by PNP Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Profectus BioSciences Inc, H2

Head And Neck Cancer - Pipeline by Provectus Biopharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by PsiOxus Therapeutics Ltd, H2

Head And Neck Cancer - Pipeline by R Pharm, H2

Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2

Head And Neck Cancer - Pipeline by Regeneron Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Reliance Life Sciences Pvt Ltd, H2

Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2

Head And Neck Cancer - Pipeline by Selecta Biosciences Inc, H2

Head And Neck Cancer - Pipeline by Shionogi & Co Ltd, H2

Head And Neck Cancer - Pipeline by Sierra Oncology Inc, H2

Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2

Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co Ltd, H2

Head And Neck Cancer - Pipeline by Sorrento Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Sound Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Spherium Biomed SL, H2

Head And Neck Cancer - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2

Head And Neck Cancer - Pipeline by SuviCa Inc, H2

Head And Neck Cancer - Pipeline by SynCore Biotechnology Co Ltd, H2

Head And Neck Cancer - Pipeline by Systimmune Inc, H2

Head And Neck Cancer - Pipeline by Taiwan Liposome Company Ltd, H2

Head And Neck Cancer - Pipeline by Takara Bio Inc, H2

Head And Neck Cancer - Pipeline by Takis Srl, H2

Head And Neck Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2

Head And Neck Cancer - Pipeline by Theralase Technologies Inc, H2

Head And Neck Cancer - Pipeline by Theravectys SA, H2

Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals Inc, H2

Head And Neck Cancer - Pipeline by Tosk Inc, H2

Head And Neck Cancer - Pipeline by Transgene SA, H2

Head And Neck Cancer - Pipeline by UbiVac LLC, H2

Head And Neck Cancer - Pipeline by Vaccibody AS, H2

Head And Neck Cancer - Pipeline by VasGene Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Vault Pharma Inc, H2

Head And Neck Cancer - Pipeline by Vaxeal Holding SA, H2

Head And Neck Cancer - Pipeline by Vectorite Biomedica Inc, H2

Head And Neck Cancer - Pipeline by Viracta Therapeutics Inc, H2

Head And Neck Cancer - Pipeline by Vyriad Inc, H2

Head And Neck Cancer - Dormant Projects, H2

Head And Neck Cancer - Discontinued Products, H2

List of Figures

Number of Products under Development for Head And Neck Cancer, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Number of Products by Top 10 Targets, H2

Number of Products by Stage and Top 10 Targets, H2

Number of Products by Top 10 Mechanism of Actions, H2

Number of Products by Stage and Top 10 Mechanism of Actions, H2

Number of Products by Top 10 Routes of Administration, H2

Number of Products by Stage and Top 10 Routes of Administration, H2

Number of Products by Top 10 Molecule Types, H2

Number of Products by Stage and Top 10 Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3SBio Inc
  • 4SC AG
  • AbbVie Inc
  • Abion Inc
  • Adaptimmune Therapeutics Plc
  • Aduro BioTech Inc
  • Advaxis Inc
  • Advenchen Laboratories LLC
  • Affimed GmbH
  • Altor BioScience Corp
  • Ambrx Inc
  • amcure GmbH
  • Amgen Inc
  • arGEN-X BV
  • ArQule Inc
  • Array BioPharma Inc
  • Ascentage Pharma Group Corp Ltd
  • Aspyrian Therapeutics Inc
  • Astellas Pharma Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • Atara Biotherapeutics Inc
  • AVEO Pharmaceuticals Inc
  • Bayer AG
  • BeiGene Ltd
  • Benitec Biopharma Ltd
  • Bexion Pharmaceuticals LLC
  • BioDiem Ltd
  • Biohaven Pharmaceutical Holding Company Ltd
  • Biomics Biotechnologies Co Ltd
  • Bionovis SA
  • BioNTech AG
  • Biotest AG
  • Biothera Pharmaceutical Inc
  • Boehringer Ingelheim GmbH
  • Boston Biomedical Inc
  • Bristol-Myers Squibb Co
  • CBT Pharmaceuticals Inc
  • CEL-SCI Corp
  • Celgene Corp
  • Cell Medica Ltd
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Celprogen Inc
  • Centrose LLC
  • Checkpoint Therapeutics Inc
  • Corvus Pharmaceuticals Inc
  • Cristal Therapeutics BV
  • Critical Outcome Technologies Inc
  • Curevac AG
  • Cyclacel Pharmaceuticals Inc
  • CytImmune Sciences Inc
  • CytomX Therapeutics Inc
  • Daiichi Sankyo Co Ltd
  • Denceptor Therapeutics Ltd
  • DNJ Pharma Inc
  • Dynavax Technologies Corp
  • Eisai Co Ltd
  • Eleven Biotherapeutics Inc
  • Eli Lilly and Co
  • Enzene Biosciences Ltd
  • Etubics Corp
  • Eureka Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Forty Seven Inc
  • Fujifilm Corp
  • G&E Herbal Biotechnology Co Ltd
  • Galectin Therapeutics Inc
  • Genelux Corp
  • Genentech Inc
  • GeneSegues Inc
  • Genexine Inc
  • Genmab A/S
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Gliknik Inc
  • Glycotope GmbH
  • Hanmi Pharmaceuticals Co Ltd
  • Hookipa Biotech AG
  • Horizon Pharma Plc
  • Hutchison MediPharma Ltd
  • Ignyta Inc
  • Immatics Biotechnologies GmbH
  • Immunocore Ltd
  • Immunomedics Inc
  • Immunovaccine Inc
  • Immunovative Therapies Ltd
  • Incyte Corp
  • Infinity Pharmaceuticals Inc
  • Innate Pharma SA
  • Innovation Pharmaceuticals Inc
  • Inovio Pharmaceuticals Inc
  • InteRNA Technologies BV
  • Iovance Biotherapeutics Inc
  • IRX Therapeutics Inc
  • ISA Pharmaceuticals BV
  • ISU ABXIS Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Johnson & Johnson
  • Jounce Therapeutics Inc
  • Juno Therapeutics Inc
  • Kite Pharma Inc
  • Kura Oncology Inc
  • Laboratoires Pierre Fabre SA
  • LATITUDE Pharmaceuticals Inc
  • Loxo Oncology Inc
  • Lytix Biopharma AS
  • Mabion SA
  • MacroGenics Inc
  • Madrigal Pharmaceuticals Inc.
  • Marsala Biotech Inc
  • Mateon Therapeutics Inc
  • MaxiVAX SA
  • Meabco A/S
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Merrimack Pharmaceuticals Inc
  • Millennium Pharmaceuticals Inc
  • Mirati Therapeutics Inc
  • Moderna Therapeutics Inc
  • Molecular Templates Inc
  • Moleculin Biotech Inc
  • NanoCarrier Co Ltd
  • NantKwest Inc
  • Natco Pharma Ltd
  • NeoImmuneTech Inc
  • Neonc Technologies Inc
  • Neumedicines Inc
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Noxopharm Ltd
  • Oncobiologics Inc
  • Oncolys BioPharma Inc
  • Onconova Therapeutics Inc
  • OncoSec Medical Inc
  • Oncovir Inc
  • Ono Pharmaceutical Co Ltd
  • Oryx GmbH & Co KG
  • Otsuka Holdings Co Ltd
  • PDS Biotechnology Corp
  • Peregrine Pharmaceuticals Inc
  • Pfizer Inc
  • Pharma Mar SA
  • Plexxikon Inc
  • PNP Therapeutics Inc
  • Profectus BioSciences Inc
  • Provectus Biopharmaceuticals Inc
  • PsiOxus Therapeutics Ltd
  • R Pharm
  • Redx Pharma Plc
  • Regeneron Pharmaceuticals Inc
  • Reliance Life Sciences Pvt Ltd
  • Sareum Holdings Plc
  • Selecta Biosciences Inc
  • Shionogi & Co Ltd
  • Sierra Oncology Inc
  • Sillajen Biotherapeutics
  • Sinil Pharmaceutical Co Ltd
  • Sorrento Therapeutics Inc
  • Sound Pharmaceuticals Inc
  • Spherium Biomed SL
  • Sumitomo Dainippon Pharma Co Ltd
  • SuviCa Inc
  • SynCore Biotechnology Co Ltd
  • Systimmune Inc
  • Taiwan Liposome Company Ltd
  • Takara Bio Inc
  • Takis Srl
  • Tessa Therapeutics Pte Ltd
  • Theralase Technologies Inc
  • Theravectys SA
  • Tolero Pharmaceuticals Inc
  • Tosk Inc
  • Transgene SA
  • UbiVac LLC
  • Vaccibody AS
  • VasGene Therapeutics Inc
  • Vault Pharma Inc
  • Vaxeal Holding SA
  • Vectorite Biomedica Inc
  • Viracta Therapeutics Inc
  • Vyriad Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll